US EditionMallinckrodt and Endo Advance Key Milestones in Strategic Merger
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Mallinckrodt and Endo Advance Key Milestones in Strategic Merger
DUBLIN, Ireland & MALVERN, PA — Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have announced significant steps forward in their proposed merger aimed at creating a global leader in specialty and generic therapeutics. With critical regulatory and legal hurdles cleared, the companies are on track to finalize the transaction in the second half of 2025. Key milestones achieved include the U.S. Securities and Exchange Commission declaring Mallinckrod…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
